UK Approves 'Landmark' Breast Cancer Drug [Barron's]
AstraZeneca PLC - American Depositary Shares (AZN)
Last astrazeneca plc - american depositary shares earnings: 2/5 04:00 pm
Check Earnings Report
US:NYSE Investor Relations:
astrazeneca.com/investor-relations.html
Company Research
Source: Barrons
Scientists described the approval of capivasertib by the National Institute for Health and Care Excellence (NICE) as a "landmark moment". More than 1,000 women with the HR-positive HER2-negative type of the disease could benefit from taking the twice-daily pill every year, NICE said. The drug, also known as Truqap and made by British pharmaceutical giant AstraZeneca, helps slow or stop the progression of the cancer, meaning it could help some patients live longer. "People with advanced breast cancer would value treatments like capivasertib that can be given when limited options exist and because it may delay the need for chemotherapy and its associated side-effects," said NICE's director of medicines evaluation, Helen Knight. The advanced type of the breast cancer has certain genetic mutations and spreads within the breast tissue or to other parts of the body. The pill works by blocking the action of an abnormal protein that tells cancer cells to multiply. Results from a
Show less
Read more
Impact Snapshot
Event Time:
AZN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AZN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AZN alerts
High impacting AstraZeneca PLC - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
AZN
News
- Top Technology Predictions Strategic Intelligence Report 2026: AI Chip Market Dynamics Shift as Nvidia's ~90% Share Faces Pressure [Yahoo! Finance]Yahoo! Finance
- ENHERTU® Granted Breakthrough Therapy Designation in the U.S. as Post-Neoadjuvant Therapy for Patients with HER2 Positive Early Breast Cancer [Yahoo! Finance]Yahoo! Finance
- Jacobio Strikes New Cancer Drug Deal with AstraZeneca [Yahoo! Finance]Yahoo! Finance
- Jacobio Pharma Enters Global Exclusive License Agreement with AstraZeneca for Pan-KRAS Inhibitor JAB-23E73 [Yahoo! Finance]Yahoo! Finance
- While IEFA is Bigger and SPDW Is More Affordable, There's 1 Subtle Difference Between These International ETFs [Yahoo! Finance]Yahoo! Finance
AZN
Sec Filings
- 12/19/25 - Form 6-K
- 12/16/25 - Form 6-K
- 12/16/25 - Form 6-K
- AZN's page on the SEC website